Clinical trial
A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced…
NCT00437749 · CBA Research, Industry · Terminated
Key facts
| NCT number | NCT00437749 |
|---|---|
| Title | A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer |
| Official title | Phase 3, Randomized, Double-Blind, Placebo-controlled Study of CBT-1 and Paclitaxel/Carboplatin in Patients With Inoperable Non-Small Cell Lung Cancer |
| Lead sponsor | CBA Research, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | CBT-1, Placebo |
| Enrollment | 214 |
| Start date | Aug 1, 2001 |
| Primary completion | Jul 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Feb 21, 2007 |
| Last update posted | Sep 9, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: